FDA aims to limit Expiration of pre-filled Avastin to 5 days

Dear Physician,   As you may be aware, recently, draft FDA guidance documents were released that provide the framework for how the agency intends on enforcing the Drug Quality and Securities Act (DQSA).   Addressed in these documents was the repackaging of certain human drugs.  Of particular concern is the agency’s intended limitations on repackaging… Read more »

Pine Pharmaceuticals participating in ASRS Practice Management Issues Seminar

Next month Pine Pharmaceuticals will be participating in the 17th Annual ASRS Practice Management Issues Seminar in Dallas, Texas.  The seminar is scheduled to take place March 27th – 29th at the Hyatt Regency Hotel.   This popular seminar is designed for retinal physicians and administrators of vitreoretinal practices to learn the business principles necessary to… Read more »

Intracameral antibiotics

2014 ASCRS endophthalmitis prophylaxis survey highlights – eyeworld.org • 67% said intracameral antibiotic prophylaxis is “important” • 47% already inject intracameral antibiotics or plan to start in the next 6 months • 49% of those not using intracameral antibiotics cite compounding or mixing risk • 75% said having an approved commercial intracameral antibiotic is “important”… Read more »

Pine Pharmaceuticals to exhibit at ‘Macula 2015’

Pine Pharmaceuticals will be exhibiting January 8 – 10th at the ‘Macula 2015’ conference in Boston.   Hosted by the Atlantic Coast Retina Club,  Macula 2015 will feature an elite group of retina specialists from around the country focusing on the latest developments in ocular imaging, management of diabetic retinopathy and retinal vein occlusion, ocular tumors,… Read more »